The Use of Patient Self-Testing in Low- and Middle-Income Countries
Authors:
- Sbongile Joyce MakhuduSMSbongile Joyce Makhudu
- Desmond KuupielDesmond Kuupiel
- Nonjabulo GwalaNGNonjabulo Gwala
- Tivani P. Mashamba-ThompsonTivani P. Mashamba-Thompson
- 1 March 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Point of Care: The Journal of Near-Patient Testing & Technology
- Vol. 18 (1) , 9-16
Abstract
Improving access to health through use of innovative health technologies such as points-of-care testing is 1 global health priority. Patient self-testing (PST) is one of the point-of-care testing strategies that was shown to have an ability to improve access to diagnostic testing, autonomy and allow access to health care for hard-to-reach populations in resource-limited settings. However, the level of evidence on the use of PST for diagnosis and management of diseases in low- and middle-income countries (LMICs) is unknown. We mapped literature on evidence of the use of PST in LMICs. Data were sourced from the following databases: PubMed; EBSCOhost (Medline, health source: Nursing), WEB of Science; Science Direct; and Google Scholar. Eligibility criteria for this study included: studies that focused on PST, reported on evidence on use of PST, conducted in LMICs, comparing PST with facility-based testing. Thematic analysis was performed to identify the patterns of use of PST. The mixed method quality appraisal tool version 2011 was used to assess the quality of the included primary studies. Eight studies met the inclusion criteria. Studies included populations from the following LMICs: Kenya; South Africa; Uganda; Bulgaria; and Malawi. Of the 18,816 total participants in all included primary studies, 57% were males. Overall, 7 (87.5%) of the 8 included studies reported on human immunodeficiency virus (HIV) self-testing using the following: oral fluid HIV self-test (HIVST), OraQuick in Home Rapid HIV-1/2 Antibody Test, OraQuick O-HIVST, oral fluid, and Fingerstick HIV self-tests. One (12.5%) of the 8 included studies reported on colorectal carcinoma using rapid immunochemical fecal occult blood tests. Although the findings of this study shows high usage of HIVST, it also demonstrates poor level of use of PST for other communicable and noncommunicable diseases in LMICs. We extracted the following themes; use of PST, feasibility of PST, and linkage to care from the included studies. Of the 8 included studies, 5 scored the highest quality (76–100%) from the methodological quality assessment. The findings of the review revealed a high level of research evidence on the use of HIV self-testing compared to other communicable diseases and noncommunicable diseases in LMICs. Increased implementation of PST for communicable diseases is recommended, particularly for high-risk and hard-to-reach populations.Keywords
This publication has 54 references indexed in Scilit:
- Oral anticoagulation and self-management: analysis of the factors that determine the feasibility of using self-testing and self-management in primary careBMC Cardiovascular Disorders, 2013
- Acceptability of HIV self-testing: a systematic literature reviewBMC Public Health, 2013
- Use of tablet-based kiosks in the emergency department to guide patient HIV self-testing with a point-of-care oral fluid testInternational Journal of STD & AIDS, 2013
- Supervised Patient Self-Testing of Warfarin Therapy Using an Online SystemJournal of Medical Internet Research, 2013
- Self-Testing and Self-Management of Warfarin Anticoagulation Therapy in Geriatric PatientsThe Consultant Pharmacist, 2013
- A Review of Self-Testing for HIV: Research and Policy Priorities in a New Era of HIV PreventionClinical Infectious Diseases, 2013
- Gay and Bisexual Men’s Views on Rapid Self-Testing for HIVAIDS and Behavior, 2013
- Scoping studies: advancing the methodologyImplementation Science, 2010
- An evidence‐based review and guidelines for patient self‐testing and management of oral anticoagulationBritish Journal of Haematology, 2005
- Patient self‐testing is a reliable and acceptable alternative to laboratory INR monitoringBritish Journal of Haematology, 2004